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Background: This is the first study that has examined non-cardiac incidental findings in research cardiac computed
tomography (CT) of hemodialysis patients and their relationship with patient characteristics.
Methods: We performed a cross-sectional analysis in the Predictors of Arrhythmic and Cardiovascular Events in End-Stage
Renal Disease (PACE) study, a prospective cohort study on incident hemodialysis patients. Non-cardiac structures
in the cardiac CT scan were reviewed and evaluated. The type and frequencies of non-cardiac incidental CT findings
were summarized. Univariate and multivariate logistic regression were performed to analyze the associations between
gender, older age, obesity, history of cardiovascular disease (CVD), smoking status, history of chronic pulmonary disease
and history of cancer with presence of any incidental CT findings and, separately, pulmonary nodules.
Results: Among the 260 participants, a total of 229 non-cardiac incidental findings were observed in 145 participants
(55.8% of all participants). Of these findings, pulmonary nodules were the most common incidental finding
(24.2% of all findings), and 41.3% of them requiring further follow-up imaging per radiology recommendation.
Vascular and gastrointestinal findings occurred in 11.8% and 15.3% of participants, respectively. Participants
65 years or older had a higher odds of any incidental findings (Odds Ratio (OR) =2.55; 95% Confidence Intervals
(CI) 1.30, 4.99) and pulmonary nodules (OR = 4.80; 95% CI 2.51, 9.18). Prior history of CVD was independently and
significantly associated with any incidental findings (OR = 2.00; 95% CI 1.19, 3.40); but not with the presence of
pulmonary nodules.
Conclusions: We demonstrate that the prevalence of incidental findings by cardiac CT scanning is extremely
high among patients on hemodialysis. Further investigations to follow-up on the high occurrence of incidental findings
during our research study and potentially clinical studies raises important practical, ethical and medico-legal issues that
need to be carefully considered in research projects using imaging studies.
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Cardiac computed tomographic (CT) angiography is a
powerful noninvasive technique for the evaluation of
coronary artery disease (CAD) and cardiac structure. An
important advantage of cardiac CT over other noninva-
sive tests for CAD is its ability to directly visualize cor-
onary arteries, aortic, and other cardiac structures and
determine additional measures of calcification of coron-
aries and valves. Simultaneously, portions of non-cardiac
structures in the chest and upper abdomen are also vis-
ible on the scan and abnormalities in these anatomic re-
gions can be detected. There have been several studies
among non-dialysis patients with suspected CAD describ-
ing non-cardiac incidental CT findings [1-12]. The preva-
lence of these non-cardiac incidental findings ranges from
8% to 69% depending on the type of CT protocol used
and age of the participants; with the most frequent in-
cidental CT finding being pulmonary nodules. There
are few studies investigating incidental CT findings in
chronic conditions such as those patients on chronic
dialysis where CT imaging for clinical indications is
done frequently.
End-stage renal disease (ESRD) patients experience a
very high incidence of cardiovascular events, particularly
sudden cardiac death, possibly caused by left ventricular
hypertrophy, electrolyte derangement and vascular calci-
fication among other causes [13,14]. In the Predictors of
Arrhythmic and Cardiovascular Events in End-Stage
Renal Disease (PACE) study, incident hemodialysis pa-
tients underwent cardiac CT scan for the evaluation of
coronary artery disease as well as coronary and valvular
calcification. Meanwhile, non-cardiac structures in the
CT scan were also reviewed and evaluated on a routine
basis.
To our knowledge no other study has reported the
prevalence of incidental findings in cardiac CT scans of
hemodialysis patients and their relationship with patient
characteristics. Therefore, the current study sought to
describe the prevalence of non-cardiac incidental find-
ings by cardiac CT in incident hemodialysis patients, to
demonstrate the nature and frequency of different inci-
dental findings in this population and to investigate the
potential associations of hemodialysis patients’ charac-
teristics with these incidental findings.
Methods
Study population
The Predictors of Arrhythmic and Cardiovascular Risk in
ESRD (PACE) study is an ongoing prospective cohort
study in the greater Baltimore area in Maryland, with the
primary goal of investigating risk factors for sudden car-
diac death and disorders of cardiac autonomic regula-
tion and ventricular conduction in patients with incident
ESRD treated with hemodialysis. Enrollment began inNovember 2008 and participants were recruited through
identifying and screening of incident participants in the
outpatient dialysis units (24 DaVita units and 2 MedStar
Units). Eligible hemodialysis patients were aged 18 years
or older, started hemodialysis within six months of enroll-
ment and were able to provide informed consent. Partici-
pants were excluded if they were on home dialysis, had
active cancer other than nonmelanoma skin cancer, had a
pacemaker/automatic implantable cardioverter defibrilla-
tor, or were pregnant or nursing mothers. At baseline,
information on participants’ demographics, medical his-
tory, questionnaires (including physical activity, cognitive
function, quality of life, frailty and diet), imaging studies
(including cardiac CT and echocardiogram), pulse wave
velocity, ankle-brachial index, electrocardiograms and
blood samples were collected on nondialysis days. Partici-
pants were followed every 6 months by telephone for
medical history and diet and every 12 months with
repeated electrocardiograms, pulse wave velocity, ankle-
brachial index, blood collection and follow-up question-
naires. Participants’ medical records were thoroughly
reviewed by trained physician adjudicators to assess base-
line comorbidities at initiation of hemodialysis.
The study protocol was approved by the institutional
review board of The Johns Hopkins School of Medicine,
MedStar Health Systems and by the medical director of
each dialysis unit. All participants provided informed
written consent. The current cross-sectional analysis in-
cluded the first 260 participants who underwent a car-
diac CT measurement as part of the PACE study
protocol and had data collected during the enrollment
study visit.
Assessment of outcomes
Each participant underwent a cardiac CT using the
Toshiba Aquilon One, 320-row detector CT scanner
(Tokyo, Japan) as part of the PACE protocol for quantifi-
cation of the burden of coronary atherosclerosis and calci-
fication. The study protocol minimized radiation to 5–7
Millisievert (mSv). Minimal dose of non-ionic, low osmo-
lar contrast was also given to the participants without a
contraindication to intravenous contrast. A single pro-
spective ECG-triggered acquisition was acquired in mid-
diastole within one R to R interval of a single heartbeat.
After the completion of the scan, a trained cardiologist
reviewed the CT images to determine if there was a
critical/urgent alert based on clinical judgment. At the
request of the investigators, trained radiologists subse-
quently read independently all CT images to assess for
non-cardiac pathologies and submitted a separate re-
port of these findings within a week. To handle critical
or urgent alerts, the cardiologist and radiologist were
provided with a weekly call schedule including the PACE
investigators (BGJ, SMS, TS, JJS) contact information.
Table 1 Type and frequency of non-cardiac incidental CT
findings among 260 incident hemodialysis study
participants
Incidental findings Number (%)
Pulmonary nodule* 63 (27.5)
Pleural effusion 23 (10.0)
Pericardial effusion 23 (10.0)
Hiatal hernia 17 (7.4)
Mediastinal lymph node** 16 (7.0)
Aortic aneurysm 14 (6.1)
Pulmonary cyst bleb 9 (4.0)
Pulmonary embolism 5 (2.2)
Abdominal mass*** 5 (2.2)
Thrombus of central venous catheter 3 (1.3)
Other 51 (22.3)
Total 229
*Nodules: 46 (73%) of them less than 6 mm; 11 (17.5%) of them between 6
and 9 mm and 6 (9.5%) of them more than 10 mm.
**Mediastinal lymph nodes: 10 (62.5%) of them less than 10 mm and 6 (37.5%)
of them 10 mm or more.
***Abdominal mass: 4 of them were in the liver and one was in the left
adrenal gland.
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base containing the participants contact information,
emergency contact person and their physicians’ name and
contact information.
Assessment of other variables
Age, sex, and race were self-reported. Body mass index
(BMI) was calculated as weight in kilograms divided by
the square of the height in meters. “Ever smoking” was
defined as self-reported lifetime exposure of at least 100
cigarettes (approximately 5 packs). Existing cardiovascular
disease (CVD) was defined as self-reported or physician-
diagnosed history of coronary artery disease, prior coron-
ary revascularization by balloon angioplasty, stenting or
bypass surgery, heart failure, stroke, transient ischemic at-
tack or peripheral vascular disease. Prevalent chronic lung
disease was defined as self-reported, physician diagnosed
asthma or reactive airway disease, or ever being treated
for these conditions. History of cancer was self-reported if
diagnosed or treated within the last 5 years of starting
dialysis.
Statistical analysis
We performed Pearson’s chi-squared test to examine if
the distribution of categorical variables (male gender,
white race, age ≥ 65 years, BMI ≥ 30 kg/m2, history of
CVD, smoking status, history of chronic lung disease,
history of cancer) were similar between participants with
and without incidental findings and between participants
with and without pulmonary nodules, the most common
finding in our population. Logistic regression was per-
formed to analyze the univariate associations between
male, older age, obesity, smoking status, history of CVD,
chronic lung disease and cancer with the presence of
any incidental CT findings and/or pulmonary nodules.
Multivariate logistic regression adjusted for age, gender,
BMI, smoking status and history of CVD was performed
to account for potential confounders. Associations were
presented as odds ratios (OR), 95% confidence intervals
and p values less than 0.05 were considered statistically
significant. Stata 11 (StataCorp LP, College Station,
Texas, USA) was used for analysis.
Results
Among the first 260 participants who completed the car-
diac CT scanning protocol, the mean age of the partici-
pants was 55 years (standard deviation (SD) ± 13.5 years)
and 57.7% of them were male. A total of 229 non-
cardiac incidental findings were observed in 145 partici-
pants (55.8% of all participants), and 42 participants
(16.2% of all participants) had two or more non-cardiac
incidental findings. Of these findings, pulmonary nod-
ules were the most common incidental finding observed
in 63 participants (24.2% of all participants), and 41.3%of them required further follow-up imaging per radi-
ology recommendation.
The nature and frequency of the clinically significant
incidental findings are presented in Table 1. Besides
pulmonary nodules (n = 63), the five most common
non-cardiac incidental findings were pleural effusions
(n = 23), pericardial effusions (n = 23), hiatal hernias (n = 17),
mediastinal lymph nodes (n = 16) and aortic aneurysms
(n = 14); two associated with dissection. Of the 63 nod-
ules, 46 (73%) of them were less than 6 mm; 11 (17.5%)
of them were between 6 and 9 mm and 6 (9.5%) of
them were more than 10 mm. The distribution of re-
gions of the 229 non-cardiac incidental findings are
presented in Figure 1. Nearly half (45.9%) of the inci-
dental findings were observed in the pulmonary region.
Figure 2 illustrates a pulmonary nodule. The gastro-
intestinal (15.3%) and vascular regions (11.8%) also had
high prevalence of abnormalities. Other findings were
observed in the abdomen (Figure 3 illustrates a liver le-
sion), but also breast, bone and soft tissue regions in a
descending order. Most notably, we discovered 5 partic-
ipants with pulmonary embolism who were immedi-
ately referred to the emergency department for further
evaluation and treatment.
The characteristics of the participants by their status
of any incidental findings and pulmonary nodules are
presented in Table 2. The percentage of older partici-
pants (age ≥ 65 years) was much greater in the group
with any incidental findings (29.7% versus 13%) and with
pulmonary nodules (46% versus 14.7%) than their
Lung (45.9%) Gastrointestinal (15.3%)
Vascular (11.8%) Bone (1.7%)
Abdomen (6.1%) Breast (4.4%)
soft tissue (1.7%) Others (13.1%)
Figure 1 Distribution of non-cardiac incidental CT findings by
organ system among 260 incident hemodialysis study participants.
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ticipants with no incidental findings were more likely to
be obese (BMI ≥ 30 kg/m2) than participants with any in-
cidental findings (P = 0.009); however, this association
was not significant when comparing participants with and
without pulmonary nodules (P = 0.6). The percentage of
participants with prior CVD was significantly higher in
the group with any incidental findings (53.5% versus
33.9%) and with pulmonary nodules (55.6% versus 41.1%)
than their counterparts (p = 0.002 and p = 0.048, respect-
ively). Interestingly, there was no difference between the
groups by gender, race, smoking status, history of chronic
lung disease and history of cancer (P > 0.05).Figure 2 A 1.3 cm × 0.8 cm nodule in the left lung lower lobe.Clinical correlates including male gender, older age,
obesity, smoking status, history of CVD, chronic lung
disease and cancer associated with the presence of any
incidental findings or pulmonary nodules are presented
in Table 3. Incident hemodialysis participants who were
65 years or older had approximately three times higher
odds of having any incidental CT findings (OR = 2.81,
95% CI 1.47, 5.38) and five times higher odds of having
pulmonary nodules (OR = 4.94, 95% CI 2.62-9.31) com-
pared to participants less than 65 years old. Similarly,
participants with a history of CVD had a significantly
higher odds of any incidental CT findings (OR = 2.24,
95% CI 1.35, 3.72) and pulmonary nodules (OR = 1.77,
95% CI 1.00, 3.15) compared with participants without
prior CVD. On the other hand, obese participants had a
significantly lower odds of having any incidental CT
findings (OR = 0.5, 95% CI 0.30, 0.84) compared to non-
obese participants. There was no association between
obesity and finding of pulmonary nodules (OR = 1.16,
95% CI 0.64, 2.10).
In the multivariate model (Table 3), after adjusting for
age, gender, BMI, smoking status and history of CVD,
these associations were slightly attenuated, but remained
statistically significant, except for the association between
prior history of CVD and pulmonary nodules. Male gender,
smoking status, history of chronic lung disease and cancer
were not associated with the presence of any incidental
findings or pulmonary nodules. In sensitivity analyses, after
removing pulmonary nodules from the incidental findings,
obese participants were still significantly less likely to have
any incidental findings compared to non-obese partici-
pants. Further, adding race to the multivariate model did
not modify the observed associations.
Figure 3 A left liver lobe lobulated hypodense lesion 2.2 × 1.9 cm.
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In this cross-sectional study, we demonstrate that the
prevalence of incidental findings by cardiac CT scanning is
extremely high among persons starting hemodialysis ther-
apy undergoing a study for research purposes and not
clinical indications. Pulmonary nodules were the most fre-
quently encountered incidental finding. Also, among par-
ticipants age 65 and older, the mean age of the US dialysis
population, there was a three times higher odds of non-
cardiac incidental findings and they were almost five times
more likely to have pulmonary nodules discovered. Prior
history of CVD was independently and significantly asso-
ciated with any incidental findings, but not with the pres-
ence of pulmonary nodules. In contrast, obese participants
did not have a higher presence of any incidental findings.
Interestingly, neither smoking status nor history ofTable 2 Characteristics of 260 hemodialysis study participant
No incidental findings Any incidental findin
n = 115 n = 145
n (%) n (%)
Male 63 (54.8) 87 (60.0)
Whites 30 (26.1) 44 (30.3)
Age≥ 65 years 15 (13.0) 43 (29.7)
BMI*≥ 30 kg/m2 49 (42.6) 39 (27.1)
Prevalent CVD 39 (33.9) 77 (53.5)
Ever smoking 64 (55.7) 89 (61.8)
Chronic pulmonary disease 26 (22.8) 27 (19.0)
Cancer 6 (5.3) 6 (4.2)
*BMI: body mass index.chronic pulmonary disease was associated with any inci-
dental findings or pulmonary nodules. The cardiovascular
imaging studies were conducted in the context of the high
burden of cardiovascular disease among patients on dialy-
sis; however, they were collected as part of a clinical re-
search study in asymptomatic conditions. The findings of
this study highlight some important issues related to con-
ducting imaging studies for dialysis patients often required
for clinical evaluation in practice. Often incidental findings
require follow-up and potentially further imaging using
ionizing radiation to reassess the initial findings, follow-up
for progression and potential intervention.
To the best of our knowledge, the current study is the first
to describe the non-cardiac incidental CT findings among
patients recently initiated on maintenance hemodialysis.
These findings expand our current knowledge. First, a clears by incidental findings and pulmonary nodules
gs No pulmonary nodules Presence of
pulmonary nodules
n = 197 n = 63
P value n (%) n (%) P value
0.4 82 (41.6) 28 (44.4) 0.7
0.5 50 (25.4) 24 (38.1) 0.05
0.001 29 (14.7) 29 (46.0) <0.001
0.009 65 (33.0) 23 (36.5) 0.6
0.002 81 (41.1) 35 (55.6) 0.048
0.3 111 (56.4) 42 (66.7) 0.2
0.5 37 (18.8) 16 (25.4) 0.3
0.678 10 (5.1) 2 (3.2) 0.522
Table 3 Association with the presence of any incidental CT findings and pulmonary nodules among 260 incident
hemodialysis study participants
Univariate model Multivariate model*
Outcomes Variables Odds ratio (95% CI) P value Odds ratio (95% CI) P value
Any incidental CT findings Male 1.24 (0.56, 2.03) 0.40 1.12 (0.65, 1.90) 0.71
Age≥ 65 years 2.81 (1.47, 5.38) 0.002 2.55 (1.30, 4.99) 0.006
BMI**≥ 30 kg/m2 0.50 (0.30, 0.84) 0.009 0.53 (0.30, 0.92) 0.024
Prevalent CVD*** 2.24 (1.35, 3.72) 0.002 2.00 (1.19, 3.40) 0.009
Ever smoking 1.29 (0.78, 2.12) 0.32 1.09 (0.64, 1.85) 0.76
Chronic pulmonary disease 0.80 (0.43, 1.46) 0.46 0.87 (0.44, 1.72) 0.69
History of cancer 0.78 (0.24, 2.50) 0.68 0.39 (0.10, 1.47) 0.17
Pulmonary Nodule Male 0.89 (0.50, 1.58) 0.69 0.96 (0.50, 1.82) 0.89
Age≥ 65 years 4.94 (2.62, 9.31) <0.001 4.80 (2.51, 9.18) <0.001
BMI**≥ 30 kg/m2 1.16 (0.64, 2.10) 0.63 1.28 (0.65, 2.48) 0.48
Prevalent CVD*** 1.77 (1.00, 3.15) 0.05 1.42 (0.77, 2.62) 0.26
Ever smoking 1.53 (0.85, 2.78) 0.16 1.50 (0.79, 2.86) 0.22
Chronic pulmonary disease 1.48 (0.75, 2.89) 0.26 1.55 (0.73, 3.29) 0.26
History of cancer 0.61 (0.13, 2.85) 0.53 0.21 (0.04, 1.06) 0.06
*Multivariate model adjusted for gender, age, BMI, smoking status, chronic pulmonary disease, history of cancer and prevalent CVD.
**BMI: body mass index.
***CVD: cardiovascular disease.
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incidental findings enables a better understanding of the
pathologic spectrum of the chest and upper abdomen re-
gions detected by cardiac CT screening in this high-risk
population. The high prevalence of incidental CT findings
and pulmonary nodules in our population is similar or
higher than what has been reported in previous studies de-
pending on the patient populations [6,9,11,14,15]. Second,
our study implemented a CT reading protocol including
timely preliminary reading and careful final reading, which
not only makes sure that we identified any critical/urgent
alerts quickly, but also enables all CT images being system-
atically reviewed without compromising validity. Import-
antly, this protocol potentially saved the life of some
asymptomatic participants with pulmonary embolism and
even thoracic aortic aneurysm. The study investigators and
the participants’ physicians were immediately notified and
necessary management steps were taken avoiding potentially
life-threatening consequences. In these cases, our partici-
pants immediately and directly benefited from the research
cardiac CT scan. Despite the significant benefit seen in these
study participants, there are a greater number of partici-
pants that will require follow-up based on the pulmonary
nodules with additional ionizing radiation and incurring
more costs to the medical system. The risks and benefits to
study participants need to be considered in order to deter-
mine the incremental net benefit of the research study aims
versus the risk of incidental findings.
In the current analysis, we examined associations be-
tween common sociodemographic and clinical risk factorslikely to be associated with incidental findings and pul-
monary nodules. Not too surprisingly, older age was sig-
nificantly associated with both incidental findings and
pulmonary nodules. Obesity and history of CVD were
only significantly associated with any incidental findings,
but not pulmonary nodules; however, this may be related
to a smaller sample size or the association was driven
mainly by other abnormalities. Interestingly, we found no
association between smoking status or history of chronic
pulmonary disease with either any incidental findings or
pulmonary nodules. This again may be due to our limited
sample size or maybe due to misclassification bias intro-
duced by self-reported smoking history.
The results of the current study should be interpreted
with some considerations in mind. First, there have been
numerous publications describing the prevalence of inci-
dental CT findings in different populations [1-12,16,17]
ranging from 8% to 69%; however, no studies in the dia-
lysis population have been published to our knowledge.
These results should be considered and utilized with
caution, as clinical imaging used in research requires ne-
cessary protocols to deal with the high volume of unex-
pected findings especially using new CT acquisition
protocols, better equipment resulting in improved ana-
tomic definition and increased chances of more incidental
findings. Generally, cardiac CT scan is viewed separately
from pulmonary scans due to the difference in scanning
region and CT modalities [15] and non-contrast calcium
scoring CT has lower power in detecting incidental find-
ings than coronary CT angiography [14]. The researchers’
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research participants remains a controversial issue as the
clinical follow-up may require significant and immediate
intervention. Additionally, there needs to be an organized
plan for a timely reading of the CT scan with eventual
clinical follow-up but also importantly the debate focuses
on the costs of causing increased anxiety and unnecessary
exposure to further radiation. The long-term treatment
and the benefits of preventing diseases for incidental find-
ings are not clear. The most recent recommendations
classified incidental findings into three categories: “strong
net benefit”; “possible net benefit”; and “unlikely net bene-
fit”, depending on the severity of the incidental findings
and the possibility of avoiding and ameliorating these con-
ditions and the recommended action for these three cat-
egories in terms of disclosure to research participants are
“disclose”, “may disclose” and “do not disclose”, respect-
ively [18]. Large-field reconstruction for pulmonary cancer
detection and serial CT scans to follow-up pulmonary
nodules are not recommended due to high false positive
rate and limited benefits [19]. A well-accepted guideline
was proposed by the Fleischner Society in 2006 [20]. The
recommended follow-up varies depending on the size of
the pulmonary nodules and patients’ risk factors. In re-
search studies, however, it may be difficult to evaluate
study participants’ risk if such information is not within
the scope of the study protocol.
Nevertheless, some limitations of the current study
need to be considered. Since the primary aim of per-
forming cardiac CT scan is to measure coronary calcium
score and atherosclerosis, there may be some self-
selection with sicker patients enrolling in the study be-
cause of free access to several cardiovascular tests. For
those suspicious nodules undergoing further evaluation,
we were not able to acquire follow-up information about
the final clinical outcome since this was outside the scope
of the study and with limited follow-up time. As a result,
the validity and false positive rate of these incidental find-
ings could not be assessed. Finally, we found no association
between pulmonary nodules and smoking status, history of
chronic lung disease or cancer. The smaller sample size of
our cohort may have led to this lack of statistical associ-
ation. However, other important potential explanations for
this lack of statistical association could be due to the exclu-
sion of patients with active cancer from the cohort and also
to the relatively younger age of our population (mean age
of 55 years). Because of the characteristics of our cohort,
these results may not be generalizable to the entire
hemodialysis population in the United States.
Conclusions
Incidental findings by cardiac CT scan are extremely
common among dialysis patients and pulmonary nodules
are the most common findings. The current study, forthe first time, describes the prevalence, the nature and
frequency of non-cardiac CT findings captured by cardiac
CT screening in asymptomatic incident hemodialysis par-
ticipants. The excessive occurrence of these incidental
findings requiring further investigations in this high-risk
population raises important practical, ethical and medico-
legal issues that need to be carefully considered in research
projects using imaging studies.
Abbreviations
CT: Computed tomography; CVD: Cardiovascular disease; OR: Odds Ratio;
CI: Confidence Intervals; CAD: Coronary artery disease; ESRD: End-stage renal
disease; mSv: Millisievert; BMI: Body mass index; SD: Standard deviation.Competing interests
The authors declare that they have no competing interest.Authors’ contributions
BGJ participated in study conception and design, analysis planning,
determination of inferences, and drafting of the manuscript. LZ conducted
the statistical analysis and participated in analysis planning, determination of
inferences and drafting of the manuscript. SVC participated in analysis
planning, chart review, determination of inferences and critical review of the
manuscript. SMS participated in analysis planning, chart review, determination
of inferences and critical review of the manuscript. TS participated in analysis
planning, determination of inferences and critical review of the manuscript. JJS
participated in analysis planning, chart review, determination of inferences and
critical review of the manuscript. GFT participated in study conception and
design, analysis planning, determination of inferences, and critical review of the
manuscript. JACL participated in study conception and design, analysis
planning, determination of inferences, and critical review of the manuscript.
WHLK participated in study conception and design, analysis planning,
determination of inferences, and critical review of the manuscript. RSP
participated in study conception and design, analysis planning, determination
of inferences, and critical review of the manuscript. LAM participated in study
conception and design, analysis planning, statistical analysis, determination of
inferences, and critical review of the manuscript. All authors read and approved
the final manuscript.Acknowledgements
We thank our participants, nephrologists and staff of the DaVita and MedStar
dialysis units in the Baltimore area who contributed to the PACE study. We
would also like to thank the participation of dialysis practices in Baltimore, in
particular, the Mid-Atlantic Nephrology Associates and the Nephrology Center
of Maryland. We thank the PACE study and the Johns Hopkins GCRC staff for
their effort, and the members of the Data Safety Monitoring Board of the
study, Drs. Paul Scheel, Luis Gimenez and Roger Blumenthal. The study and
faculty were supported by the NIDDK-R01DK072367 (Parekh, Kao and
Meoni), DK-083514 (Shafi), DK095949 (Scialla), and the National Center for
Research Resources - NIH Roadmap for Medical Research (Scialla).
Author details
1Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD,
USA. 2Department of Epidemiology, Johns Hopkins Bloomberg School of
Public Health, Baltimore, MD, USA. 3Welch Center for Prevention,
Epidemiology and Clinical Research, Johns Hopkins Medical Institutions,
Baltimore, MD, USA. 4Nephrology Center of Maryland, Baltimore, MD, USA.
5Jacobi Medical Center, Bronx, NY, USA. 6Greater Baltimore Medical Center,
Baltimore, MD, USA. 7Department of Medicine, University of Miami Miller
School of Medicine, Miami, FL, USA. 8Departments of Pediatrics, Hospital for
Sick Children and Medicine, University Health Network, University of Toronto,
Ontario, Canada. 9Department of Biostatistics, Johns Hopkins Bloomberg
School of Public Health, Baltimore, MD, USA.
Received: 17 August 2013 Accepted: 24 April 2014
Published: 1 May 2014
Jaar et al. BMC Nephrology 2014, 15:68 Page 8 of 8
http://www.biomedcentral.com/1471-2369/15/68References
1. Elgin EE, O’Malley PG, Feuerstein I, Taylor AJ: Frequency and severity of
“incidentalomas” encountered during electron beam computed
tomography for coronary calcium in middle-aged army personnel. Am J
Cardiol 2002, 90:543–545.
2. Law YM, Huang J, Chen K, Cheah FK, Chua T: Prevalence of significant
extracoronary findings on multislice CT coronary angiography
examinations and coronary artery calcium scoring examinations. J Med
Imag Radiat On 2008, 52:49–56.
3. Schietinger BJ, Bozlar U, Hagspiel KD, Norton PT, Greenbaum HR, Wang H,
Isbell DC, Patel RA, Ferguson JD, Gay SB, Kramer CM, Mangrum JM: The
prevalence of extracardiac findings by multidetector computed
tomography before atrial fibrillation ablation. Am Heart J 2008,
155:254–259.
4. Koonce J, Schoepf JU, Nguyen SA, Northam MC, Ravenel JG: Extra-cardiac
findings at cardiac CT: experience with 1,764 patients. Eur Radiol 2009,
2009(19):570–576.
5. Kawano Y, Tamura A, Goto Y, Shinozaki K, Zaizen H, Kadota J: Incidental
detection of cancers and other non-cardiac abnormalities on coronary
multislice computed tomography. Am J Cardiol 2007, 99:1608–1609.
6. Gil BN, Ran K, Tamar G, Shmuell F, Eli A: Prevalence of significant noncardiac
findings on coronary multidetector computed tomography angiography in
asymptomatic patients. J Comput Assist Tomogr 2007, 31:1–4.
7. Kirsch J, Araoz PA, Steinberg FB, Fletcher JG, McCollough CH, Williamson EE:
Prevalence and significance of incidental extracardiac findings at 64-
multidetector coronary CTA. J Thorac Imaging 2007, 22:330–334.
8. Haller S, Kaiser C, Buser P, Bongartz G, Bremerich J: Coronary artery
imaging with contrast-enhanced MDCT: extracardiac findings. AJR Am J
Roentgenol 2006, 187:105–110.
9. Onuma Y, Tanabe K, Nakazawa G, Aoki J, Nakajima H, Ibukuro K, Hara K:
Noncardiac findings in cardiac imaging with multidetector computed
tomography. J Am Coll Cardiol 2006, 48:402–406.
10. Mueller J, Jeudy J, Poston R, White CS: Cardiac CT angiography after
coronary bypass surgery: prevalence of incidental findings. AJR Am J
Roentgenol 2007, 189:414–419.
11. Hunold P, Schmermund A, Seibel RM, Gronemeyer DH, Erbel R:
Prevalence and clinical significance of accidental findings in electron-
beam tomographic scans for coronary artery calcification. Eur Heart J
2001, 22:1748–1758.
12. Horton KM, Post WS, Blumenthal RS, Fishman EK: Prevalence of significant
noncardiac findings on electron-beam computed tomography coronary
artery calcium screening examinations. Circulation 2002, 106:532–534.
13. Green D, Roberts PR, New DI, Kalra PA: Sudden cardiac death in
hemodialysis patients: an in-depth review. Am J Kidney Dis 2011,
57:921–929.
14. Killeen RP, Cury RC, McErlean A, Dodd JD: Noncardiac findings on cardiac
CT. Part II: spectrum of imaging findings. J Cardiovasc Comput Tomogr
2009, 3:361–371.
15. Jacobs PC, Mali WP, Grobbee DE, van der Graaf Y: Prevalence of incidental
findings in computed tomographic screening of the chest: a systematic
review. J Comput Assist Tomogr 2008, 32:214–221.
16. Chia PL, Kaw G, Wansaicheong G, Ho KT: Prevalence of non-cardiac findings
in a large series of patients undergoing cardiac multi-detector computed
tomography scans. Int J Cardiovasc Imaging 2009, 25:537–543.
17. Schragin JG, Weissfeld JL, Edmundowicz D, Strollo DC, Fuhrman CR: Non-
cardiac findings on coronary electron beam computed tomography
scanning. J Thorac Imaging 2004, 19:82–86.
18. Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, Fletcher JG,
Georgieff MK, Hammerschmidt D, Hudson K, Illes J, Kapur V, Keane MA,
Koenig BA, Leroy BS, McFarland EG, Paradise J, Parker LS, Terry SF, Van Ness
B, Wilfond BS: Managing incidental findings in human subjects research:
analysis and recommendations. J Law Med Ethics 2008, 36:219–248.19. Budoff MJ, Gopal A: Incidental findings on cardiac computed
tomography. Should we look? J Cardiovasc Comput Tomogr 2007,
1:97–105.
20. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, Patz EF Jr,
Swensen SJ: Guidelines for management of small pulmonary nodules
detected on CT scans: a statement from the Fleischner Society. Radiology
2005, 237:395–400.
doi:10.1186/1471-2369-15-68
Cite this article as: Jaar et al.: Incidental findings on cardiac computed
tomography in incident hemodialysis patients: the predictors of
arrhythmic and cardiovascular events in end-stage renal disease (PACE)
study. BMC Nephrology 2014 15:68.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
